|
Jul 25
|
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Gain 1.6% for Week
|
|
Jul 24
|
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
|
|
Jul 22
|
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
|
|
Jul 18
|
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
|
|
Jul 17
|
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
|
|
Jul 16
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|
|
Jul 15
|
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
|
|
Jun 26
|
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
|
|
Apr 9
|
IBL partners with Grifols to develop biomarker panels for speciality diagnostics
|
|
Apr 8
|
Exploring High Growth Tech Stocks In Europe April 2025
|
|
Jan 2
|
Exploring Three High Growth Tech Stocks For Future Potential
|
|
Jul 29
|
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients
|
|
Jul 12
|
Three Stocks Estimated To Be Trading With Intrinsic Discounts Between 35.9% And 49.7%
|
|
Jul 9
|
Grifols Family Shareholders, Brookfield in Talks To Take Firm Private
|
|
Jul 8
|
European Equities Close Mixed in Monday Trading
|
|
Jul 8
|
Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why
|
|
Jun 18
|
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
|
|
Jun 17
|
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies
|
|
May 9
|
Short Seller Gains on Grifols Bet That Tripped Elliott Spinout
|
|
Mar 22
|
Grifols Drops as Regulator Finds ‘Relevant Deficiencies’
|